What is most important is the trends with the infected group. With such a small placebo sample (3-5 people?), it is hard to draw much from them.
The t-cell response it what Prof Frazer is really looking for. He wants to rid the body of the disease entirely, and this is probably the best method of doing so - outside of nanopartcile technology.
Ann: HSV-2 Interim Results Announcement-AHZ.AX, page-41
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
-0.500(3.19%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.75 | $15.75 | $15.00 | $294.3K | 19.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1135 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.35 | 88 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |